This inventor holds 3 USPTO granted patents. Top assignee: Bantam Pharmaceutical, LLC. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Jedd Levine: Innovator in Cancer Treatment
Introduction
Jedd Levine is a notable inventor based in Litchfield, CT (US). He has made significant contributions to the field of medicine, particularly in the treatment of hyperproliferative diseases such as cancer. With a total of 3 patents, Levine's work focuses on innovative methods and compounds that target cancer cells effectively.
Latest Patents
Levine's latest patents include groundbreaking methods of using substituted pyrazole and pyrazole compounds for the treatment of hyperproliferative diseases. These patents disclose methods for treating hyperproliferative disorders, including cancer, by arresting the cell cycle in cancer cells and inhibiting glutathione synthesis. The compounds referenced in these patents are particularly effective against cancers with a mutant KRAS gene, showcasing their potential in advancing cancer treatment.
Career Highlights
Jedd Levine is currently associated with Bantam Pharmaceutical, LLC, where he continues to develop innovative solutions for cancer treatment. His work has garnered attention for its potential to improve patient outcomes in the fight against cancer.
Collaborations
Levine collaborates with talented professionals in the field, including Stephane Ciblat and Lea Constantineau-Forget. These collaborations enhance the research and development efforts at Bantam Pharmaceutical, LLC.
Conclusion
Jedd Levine's contributions to cancer treatment through his innovative patents and collaborations highlight his commitment to advancing medical science. His work is paving the way for new therapeutic approaches that could significantly impact the lives of patients battling cancer.